PIOGLITAZONE HYDROCHLORIDE
Generic: PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE
Aurobindo Pharma LimitedManufacturer
ORALRoute
PIOGLITAZONE HYDROCHLORIDEActive Substance
2013-02-13Original Approval
PIOGLITAZONE HYDROCHLORIDE is FDA application ANDA200268, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2019-09-23
Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., PlSuperpotent
Class II2021-12-29
Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC Superpotent and Failed Tablet/Capsule Specifications
Top Reported Reactions
1
NAUSEA
622 reports
2
DIARRHOEA
609 reports
3
FATIGUE
539 reports
4
DRUG INEFFECTIVE
527 reports
5
DYSPNOEA
455 reports
6
BLOOD GLUCOSE INCREASED
437 reports
7
VOMITING
429 reports
8
OFF LABEL USE
409 reports
9
ACUTE KIDNEY INJURY
378 reports
10
DIZZINESS
364 reports